TB-500 + GHK-Cu
Also known as: tb500ghkcu
Grey-market vendor blend combining TB-500 (a synthetic heptapeptide fragment of Thymosin Beta-4, not full-length Tβ4) and GHK-Cu (a copper tripeptide). This blend is not clinically validated; evidence is extrapolated from individual-component research, and no human trials of the combination exist.
Who's worth your money for TB-500 + GHK-Cu
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
No sellers for TB-500 + GHK-Cu are indexed yet — we add vendors and their prices as we find them.
Watch TB-500 + GHK-Cu
Get one email when the market actually moves — no newsletter, no noise.
About TB-500 + GHK-Cu
CAS
—
Molecular formula
—
Typical dose range
TB-500: 2–5 mg 2x/week subcutaneous; GHK-Cu: 1–2 mg/day subcutaneous (research use only)
Half-life
TB-500: ~2–3 days; GHK-Cu: ~30–60 minutes
No COAs on file for TB-500 + GHK-Cu
No independent third-party test has been located or submitted yet. Absence isn't a red flag — just no evidence catalogued for TB-500 + GHK-Cu so far; we add COAs as we find them.